353 related articles for article (PubMed ID: 30322728)
21. Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer.
Mengual L; Lozano JJ; Ingelmo-Torres M; Gazquez C; Ribal MJ; Alcaraz A
Int J Cancer; 2013 Dec; 133(11):2631-41. PubMed ID: 23686449
[TBL] [Abstract][Full Text] [Related]
22. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
Güllü Amuran G; Tinay I; Filinte D; Ilgin C; Peker Eyüboğlu I; Akkiprik M
Int Urol Nephrol; 2020 Mar; 52(3):461-468. PubMed ID: 31679136
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer.
Wang J; Zhang X; Wang L; Dong Z; Du L; Yang Y; Guo Y; Wang C
J Surg Oncol; 2015 Jun; 111(8):992-9. PubMed ID: 25975233
[TBL] [Abstract][Full Text] [Related]
24. A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade.
Hermanns T; Savio AJ; Olkhov-Mitsel E; Mari A; Wettstein MS; Saba K; Bhindi B; Kuk C; Poyet C; Wild PJ; Noon A; Bashir S; Juvet T; Rendon RA; Waltregny D; van der Kwast T; Finelli A; Kulkarni GS; Fleshner NE; Lo K; Bapat B; Zlotta AR
Urol Oncol; 2020 Jun; 38(6):603.e1-603.e7. PubMed ID: 32081560
[TBL] [Abstract][Full Text] [Related]
25. Plasma microRNA profiles for bladder cancer detection.
Adam L; Wszolek MF; Liu CG; Jing W; Diao L; Zien A; Zhang JD; Jackson D; Dinney CP
Urol Oncol; 2013 Nov; 31(8):1701-8. PubMed ID: 22863868
[TBL] [Abstract][Full Text] [Related]
26. A microRNA biomarker panel for the non-invasive detection of bladder cancer.
Urquidi V; Netherton M; Gomes-Giacoia E; Serie DJ; Eckel-Passow J; Rosser CJ; Goodison S
Oncotarget; 2016 Dec; 7(52):86290-86299. PubMed ID: 27863434
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
Xu Z; Yu YQ; Ge YZ; Zhu JG; Zhu M; Zhao YC; Xu LW; Yang XB; Geng LG; Dou QL; Jia RP
Tumour Biol; 2015 Sep; 36(10):8159-66. PubMed ID: 25990459
[TBL] [Abstract][Full Text] [Related]
28. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W
BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847
[TBL] [Abstract][Full Text] [Related]
29. Expression profile of miRNAs in urine samples of bladder cancer patients.
Nekoohesh L; Modarressi MH; Mowla SJ; Sadroddiny E; Etemadian M; Afsharpad M; Zolfaghari F; Barzegari M; Saffari M; Oskooei VK; Motevaseli E; Ghafouri-Fard S
Biomark Med; 2018 Dec; 12(12):1311-1321. PubMed ID: 30507304
[TBL] [Abstract][Full Text] [Related]
30. UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria.
Kim WT; Jeong P; Yan C; Kim YH; Lee IS; Kang HW; Kim YJ; Lee SC; Kim SJ; Kim YT; Moon SK; Choi YH; Kim IY; Yun SJ; Kim WJ
Oncotarget; 2016 Sep; 7(36):58193-58202. PubMed ID: 27528424
[TBL] [Abstract][Full Text] [Related]
31. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.
Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ
Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592
[TBL] [Abstract][Full Text] [Related]
32. Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria.
Piao XM; Jeong P; Kim YH; Byun YJ; Xu Y; Kang HW; Ha YS; Kim WT; Lee JY; Woo SH; Kwon TG; Kim IY; Moon SK; Choi YH; Cha EJ; Yun SJ; Kim WJ
Int J Cancer; 2019 Jan; 144(2):380-388. PubMed ID: 30183088
[TBL] [Abstract][Full Text] [Related]
33. Expression of microRNAs in the urine of patients with bladder cancer.
Wang G; Chan ES; Kwan BC; Li PK; Yip SK; Szeto CC; Ng CF
Clin Genitourin Cancer; 2012 Jun; 10(2):106-13. PubMed ID: 22386240
[TBL] [Abstract][Full Text] [Related]
34. Urine cell-based DNA methylation classifier for monitoring bladder cancer.
van der Heijden AG; Mengual L; Ingelmo-Torres M; Lozano JJ; van Rijt-van de Westerlo CCM; Baixauli M; Geavlete B; Moldoveanud C; Ene C; Dinney CP; Czerniak B; Schalken JA; Kiemeney LALM; Ribal MJ; Witjes JA; Alcaraz A
Clin Epigenetics; 2018; 10():71. PubMed ID: 29854012
[TBL] [Abstract][Full Text] [Related]
35. Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer.
Jiang X; Du L; Duan W; Wang R; Yan K; Wang L; Li J; Zheng G; Zhang X; Yang Y; Wang C
Oncotarget; 2016 Jun; 7(24):36733-36742. PubMed ID: 27167342
[TBL] [Abstract][Full Text] [Related]
36. The evolving understanding of microRNA in bladder cancer.
Guancial EA; Bellmunt J; Yeh S; Rosenberg JE; Berman DM
Urol Oncol; 2014 Jan; 32(1):41.e31-40. PubMed ID: 23911686
[TBL] [Abstract][Full Text] [Related]
37. Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer.
Roperch JP; Grandchamp B; Desgrandchamps F; Mongiat-Artus P; Ravery V; Ouzaid I; Roupret M; Phe V; Ciofu C; Tubach F; Cussenot O; Incitti R
BMC Cancer; 2016 Sep; 16(1):704. PubMed ID: 27586786
[TBL] [Abstract][Full Text] [Related]
38. MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology.
Yamada Y; Enokida H; Kojima S; Kawakami K; Chiyomaru T; Tatarano S; Yoshino H; Kawahara K; Nishiyama K; Seki N; Nakagawa M
Cancer Sci; 2011 Mar; 102(3):522-9. PubMed ID: 21166959
[TBL] [Abstract][Full Text] [Related]
39. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.
Motawi TK; Rizk SM; Ibrahim TM; Ibrahim IA
Cell Biochem Funct; 2016 Apr; 34(3):142-8. PubMed ID: 26916216
[TBL] [Abstract][Full Text] [Related]
40. A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance.
Sapre N; Macintyre G; Clarkson M; Naeem H; Cmero M; Kowalczyk A; Anderson PD; Costello AJ; Corcoran NM; Hovens CM
Br J Cancer; 2016 Feb; 114(4):454-62. PubMed ID: 26812572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]